Chk2(Phospho Thr68) Polyclonal Antibody BT-AP01742
Specifications
| 20ul / 50ul / 100ul |
Background:
In response to DNA damage and replication blocks| cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated| the encoded protein is known to inhibit CDC25C phosphatase| preventing entry into mitosis| and has been shown to stabilize the tumor suppressor protein p53| leading to cell cycle arrest in G1. In addition| this protein interacts with and phosphorylates BRCA1| allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome| a highly penetrant familial cancer phenotype usually associated with inherited mutati
Classification:
Primary antibody
Alternative names:
Serine/threonine-protein kinase Chk2; CHEK2; CDS1; CHK2; RAD53; Serine/threonine-protein kinase Chk2; CHK2 checkpoint homolog; Cds1 homolog; Hucds1; hCds1; Checkpoint kinase 2
Species reactivity:
Human, Mouse, Rat
Host:
Rabbit
Isotype:
IgG
Immunogen:
The antiserum was produced against synthesized peptide derived from human Chk2 around the phosphorylation site of Thr68. AA range:35-84
Concentration:
1 mg/ml
Molecular weight:
60915
Applications:
IF, ICC, WB, IHC-p, ELISA
Storage:
-20°C for 1 year
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com

As a national high-tech enterprise, KMD Bioscience focuses on providing cell line construction and screening, natural protein extraction and fermentation, customized recombinant protein expression, monoclonal and polyclonal antibody development, phage display library construction and screening services to scientists and research institutions worldwide. At the same time, based on the company's four core technology platforms, they have successfully developed numerous recombinant proteins, antibodies, antibody drug target proteins, industrial enzymes, diagnostic materials and other related reagents for scientific research.